“A bill to improve the Institutional Development Award program of the National Institutes of Health.”
No CRS summary available for this bill.
This section revises the Institutional Development Award (IDeA) program under the National Institute of General Medical Sciences (NIGMS), which enhances the competitiveness of eligible research entities in obtaining National Institutes of Health (NIH) funding for biomedical and behavioral research, by (1) officially designating the program as the "Institutional Development Award program" or "IDeA program"; (2) redefining eligible entities as those in states at or below the median of all states in aggregate NIH grant funding (excluding IDeA funding), calculated on a rolling multi-year average as determined by the NIH Director (referred to as "IDeA States")—replacing the prior standard of states with historically low aggregate success rates for NIH applications relative to other states; and (3) requiring NIH to submit to Congress, as part of its federal budget submission or via an annually updated public data source, descriptions of the program's strategy and objectives, prior-year awards (including integration efforts with major NIH activities, the percentage of IDeA-state reviewers, and updates on partnerships between IDeA and non-IDeA states), and gains in academic research quality and biomedical science workforce development over the last five fiscal years.